← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2002Last known activity
May 1, 2019
Timeline
1960s
- Jan 1, 1969
University of Science Malaysia— Founded
Drugs by trial phase (38 distinct, 30 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Amphetamine-Related Disorders
- Cerebrovascular Disorders
- Chest Pain
- Cognitive Dysfunction
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Diarrhea
- Edema
- Endotoxemia
- Esophagitis, Peptic
- Gastroesophageal Reflux
- Glucose Intolerance
- Heartburn
- Heroin Dependence
- Inflammation
- Irritable Bowel Syndrome
- Ischemia
- Macular Edema
- Metabolic Syndrome
- Polycystic Ovary Syndrome
- Prediabetic State
- Pterygium
- Recurrence
- Stroke
- Syndrome
- Thromboembolism
- Thrombosis
- Vascular Diseases
Recent trials (50)
- NCT03940612Reponsible party - principal investigatorN/AMay 1, 2019
- NCT03940612Lead sponsorN/AMay 1, 2019
- NCT03940612Overall official - principal investigatorN/AMay 1, 2019
- NCT03883685CollaboratorPhase 4Jan 1, 2019
- NCT04031859CollaboratorPhase 2Oct 10, 2018
- NCT04031859Overall official - principal investigatorPhase 2Oct 10, 2018
- NCT03468361Reponsible party - principal investigatorN/AMar 1, 2018
- NCT03468361Study directorN/AMar 1, 2018
- NCT03468361Lead sponsorN/AMar 1, 2018
- NCT03460626Lead sponsorN/AFeb 2, 2018
- NCT03460626Reponsible party - principal investigatorN/AFeb 2, 2018
- NCT03414099Lead sponsorPhase 3Jan 23, 2018
- NCT03414099Reponsible party - principal investigatorPhase 3Jan 23, 2018
- NCT03370458Lead sponsorN/ADec 1, 2017
- NCT03370458Reponsible party - principal investigatorN/ADec 1, 2017
Details
- Founded
- Penang, MY Jan 1, 1969
- Last known activity
- May 1, 2019